The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats

British Journal of Pharmacology

Volumn 151, Issue 7, 2007, Pages 1095-1102

  Rawls, S M ^a   Tallarida, R ^b   Robinson, W ^a   Amin, M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Ceftriaxone; GLT 1; Glutamate; Hyperthermia; Morphine; TBOA

Indexed keywords

ASPARTIC ACID DERIVATIVE; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MORPHINE; RILUZOLE; SODIUM CHLORIDE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BODY TEMPERATURE MEASUREMENT; CONSCIOUSNESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; ASPARTIC ACID; BETA-LACTAMS; BODY TEMPERATURE; CEFTRIAXONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEVER; GLUTAMIC ACID; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; RILUZOLE; TIME FACTORS;

EID: 34547590001     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707309     Document Type: Article

References (62)

1. Adler MW, Geller EB (1993). Physiological functions of opioids: temperature regulation. In: Herz A, Akil H, Simon EJ (eds). Handbook of Experimental Pharmacology Vol. 104/II, Opioids II. Springer-Verlag: Berlin, Germany. pp 205-238.
2. Aghajanian GK, Kogan JH, Moghaddam B (1994). Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636: 126-130.
3. Akaoka H, Aston-Jones G (1991). Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11: 3830-3839.
4. Allen RM, Dykstra LA (2001). N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. J Pharmacol Exp Ther 298: 288-297.
5. Beghi E, Bendotti C, Mennini T (2005). Merits of a new drug trial for ALS? Science 308: 632-633.
6. Benamar K, Xin L, Geller EB, Adler MW (2001). Effect of central and peripheral administration of a nitric oxide synthase inhibitor on morphine hyperthermia in rats. Brain Res 894: 266-273.
7. Boulant JA (1981). Hypothalamic mechanisms in thermoregulation. Fed Proc 40: 2843-2850.
8. Cechova S, Zuo Z (2006). Inhibition of glutamate transporters increases the minimum alveolar concentration for isoflurane in rats. Br J Anaesth 97: 192-195.
9. Chandrasekar PH, Rolston KV, Smith BR, LeFrock JL (1984). Diffusion of ceftriaxone into the cerebrospinal fluid of adults. J Antimicrob Chemother 14: 427-430.
10. Chen X, McClatchy DB, Geller EB, Liu-Chen L, Tallarida RJ, Adler MW (2001). Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin. Brain Res 904: 252-258.
11. Chen XH, Geller EB, DeRiel JK, Liu-Chen LY, Adler MW (1996). Antisense confirmation of mu- and kappa-opioid receptor mediation of morphine's effects on body temperature in rats. Drug Alcohol Depend 43: 119-124.
12. Chu K, Lee ST, Sinn DI, Ko SY, Kim EH, Kim JM et al. (2007). Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38: 177-182.
13. Danbolt NC (2001). Glutamate uptake. Prog Neurobiol 65: 1-105.
14. Doble A (1996). The pharmacology and mechanism of action of riluzole. Neurology 47: S233-S241.
15. Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M (2000). The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 57: 906-912.
16. Frizzo ME, Dall'Onder LP, Dalcin KB, Souza DO (2004). Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol 24: 123-128.
17. Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M et al. (2005). Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci 22: 2744-2754.
18. Geller EB, Hawk C, Keinath SH, Tallarida RJ, Adler MW (1983). Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration. J Pharmacol Exp Ther 225: 391-398.
19. Geller EB, Rowan CH, Adler MW (1986). Body temperature effects of opioids in rats: intracerebroventricular administration. Pharmacol Biochem Behav 24: 1761-1765.
20. Goodman LS, Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's. The Pharmacological Basis of Therapeutics. McGraw-Hill Medical Pub. Division: New York.
21. Granero L, Santiago M, Cano J, Machado A, Peris JE (1995). Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob Agents Chemother 39: 2728-2731.
22. Herman BH, Vocci F, Bridge P (1995). The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 13: 269-293.
23. Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T (1997). Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 282: 1280-1290.
24. Inturrisi CE (1997). Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence. Semin Neurosci 9: 110-119.
25. Ji HF, Shen L, Zhang HY (2005). Beta-lactam antibiotics are multi-potent agents to combat neurological diseases. Biochem Biophys Res Commun 333: 661-663.
26. Jin C, Araki H, Kawasaki Y, Nagata M, Suemaru K, Shibata K et al. (2006). The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure. Brain Res 1069: 120-126.
27. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G (1998). Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84: 583-589.
28. Le Greves P, Huang W, Zhou Q, Thornwall M, Nyberg F (1998). Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord. Eur J Pharmacol 341: 161-164.
29. Lin MT, Ho MT, Young MS (1992). Stimulation of the nigrostriatal dopamine system inhibits both heat production and heat loss mechanisms in rats. Naunyn Schmiedebergs Arch Pharmacol 346: 504-510.
30. Malgouris C, Bardot F, Daniel M, Pellis F, Rataud J, Uzan A et al. (1989). Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J Neurosci 9: 3720-3727.
31. Martin D, Thompson MA, Nadler JV (1993). The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol 250: 473-476.
32. Miller TM, Cleveland DW (2005). Medicine. Treating neurodegenerative diseases with antibiotics. Science 307: 361-362.
33. Mineur YS, Picciotto MR, Sanacora G (2007). Antidepressant-like effects of ceftriaxone in male C57BL/6J mice. Biol Psychiatry 61: 250-252.
34. Mitani A, Tanaka K (2003). Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 23: 7176-7182.
35. Nakagawa T, Satoh M (2004). Involvement of glial glutamate transporters in morphine dependence. Ann N Y Acad Sci 1025: 383-388.
36. Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H et al. (1993). Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 37: 1518-1524.
37. Ozawa T, Nakagawa T, Sekiya Y, Minami M, Satoh M (2004). Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci 19: 221-226.
38. Ozawa T, Nakagawa T, Shige K, Minami M, Satoh M (2001). Changes in the expression of glial glutamate transporters in the rat brain accompanied withmorphine dependence and naloxone-precipitated withdrawal. Brain Res 905: 254-258.
39. Prakriya M, Mennerick S (2000). Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26: 671-682.
40. Rao VL, Bowen KK, Dempsey RJ (2001). Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem Res 26: 497-502.
41. Rasmussen K, Aghajanian GK (1989). Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res 505: 346-350.
42. Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL (1991). NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur J Pharmacol 197: 9-16.
43. Rawls SM, Baron DA, Gaughan JP, Geller EB, Adler MW, Cowan A (2003). NMDA antagonists attenuate morphine-induced hyperthermia. Brain Res 984: 76-83.
44. Rawls SM, Hewson JM, Inan S, Cowan A (2005). Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats. Brain Res 1049: 61-69.
45. Rawls SM, McGinty JF (1997). L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. J Neurochem 68: 1553-1563.
46. Rebuelto M, Ambros L, Rubio M (2003). Daily variations in ceftriaxone pharmacokinetics in rats. Antimicrob Agents Chemother 47: 809-812.
47. Rothstein JD (1996). Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 3: 348-359.
48. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77.
49. Secko D (2005). Antibiotics that protect the brain. CMAJ 172: 467-468.
50. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N et al. (1998). -threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53: 195-201.
51. Shimamoto K, Shigeri Y, Yasuda-Kamatani Y, Lebrun B, Yumoto N, Nakajima T (2000). Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg Med Chem Lett 10: 2407-2410.
52. Singh J, Gupta MC (1997). Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats. Indian J Physiol Pharmacol 41: 123-128.
53. Spencer RL, Hruby VJ, Burks TF (1988). Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats. J Pharmacol Exp Ther 246: 92-101.
54. Spencer RL, Hruby VJ, Burks TF (1990). Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 252: 696-705.
55. Stefani A, Spadoni F, Bernardi G (1997). Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies. Exp Neurol 147: 115-122.
56. Tallarida RJ (2001). Drug synergism: its detection and applications. J Pharmacol Exp Ther 298: 865-872.
57. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K et al. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702.
58. Trujillo KA (2000). Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl) 151: 121-141.
59. Xi ZX, Baker DA, Shen H, Carson DS, Kalivas PW (2002). Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J Pharmacol Exp Ther 300: 162-171.
60. Xin L, Geller EB, Adler MW (1997). Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain. J Pharmacol Exp Ther 281: 499-507.
61. Yasumatsu M, Yazawa T, Otokawa M, Kuwasawa K, Hasegawa H, Aihara Y (1998). Monoamines, amino acids and acetylcholine in the preoptic area and anterior hypothalamus of rats: measurements of tissue extracts and in vivo microdialysates. Comp Biochem Physiol A Mol Integr Physiol 121: 13-23.
62. Ye ZC, Rothstein JD, Sontheimer H (1999). Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19: 10767-10777.